Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 1 |
2012 | 1 |
2013 | 1 |
2024 | 0 |
Articles frequently viewed together for PMID: 21088398
3 results
Results by year
Filters applied: . Clear all
Page 1
Meta-analysis of incidence and risk of hypomagnesemia with cetuximab for advanced cancer.
Chemotherapy. 2010;56(6):459-65. doi: 10.1159/000321011. Epub 2010 Nov 18.
Chemotherapy. 2010.
PMID: 21088398
Incidence and risk of hypomagnesemia in advanced cancer patients treated with cetuximab: A meta-analysis.
Chen P, Wang L, Li H, Liu B, Zou Z.
Chen P, et al.
Oncol Lett. 2013 Jun;5(6):1915-1920. doi: 10.3892/ol.2013.1301. Epub 2013 Apr 4.
Oncol Lett. 2013.
PMID: 23833666
Free PMC article.
Item in Clipboard
Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studies.
Petrelli F, Borgonovo K, Cabiddu M, Ghilardi M, Barni S.
Petrelli F, et al.
Expert Opin Drug Saf. 2012 May;11 Suppl 1:S9-19. doi: 10.1517/14740338.2011.606213. Epub 2011 Aug 16.
Expert Opin Drug Saf. 2012.
PMID: 21843103
Review.
Item in Clipboard
Cite
Cite